Latest
industry research report on: Global Epilepsy Therapeutics Market |
Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand,
Growth, Segmentation, Parameters, Forecasts
GBI Research has released its pharma research: ‘Epilepsy Therapeutics
in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of
Action Signal a Shift in Treatment Patterns ’, which provides in-depth
analysis of epilepsy market within the eight major developed markets of
the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report
provides an estimation of the market size for 2012, along with market
forecasts to 2019. It also covers disease epidemiology, treatment
algorithms, treatment patterns, in-depth analysis of the pipeline, and
deal analysis.
The
value of the epilepsy market in the major developed markets amounted to
an estimated $3.4 billion in 2012 and is expected to register a
Compound Annual Growth Rate (CAGR) of 3.9% to reach $4.5 billion by
2019.
This modest growth is attributed to the recent approval of drugs with
novel mechanisms of action that are expected to offer more therapeutic
options to prescribers. The US takes major share of 55% of the global
epilepsy market. In the US, three new anti-epileptic drugs have been
approved since 2012: Trobalt, Aptiom, and Fycompa and another,
brivaracetam, is expected also to be launched during the forecast
period. Of these, Trobalt and Fycompa have novel mechanisms of action
and improved safety and tolerability that elicited significant interest
from prescribers. Continued uptake of second- and third-generation
anti-epileptic drugs is also expected to contribute towards revenues in
these eight regions. However, the epilepsy market could face the
restricting influence of generic competition as a result of recent
patent expiries in all major markets of two key branded drugs, Keppra
and Lamictal.
Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/191050
Scope
- A brief introduction to epilepsy, including disease pathogenesis, risk factors, diagnosis and treatment options
- In-depth analysis of major marketed products covering product performance, product life-cycle and a heat map depicting comparative analysis of safety and efficacy parameters
- A comprehensive review of the epilepsy pipeline which includes individual analysis of promising late-stage pipeline drugs that are most likely to enter the market during the forecast period. The pipeline is analyzed on the basis of Phase distribution, molecule type and molecular target
- Additional clinical trial analysis by Phase, trial size, trial duration and program failure rate for each molecule type and mechanism of action
- Multi-scenario forecasts of the epilepsy market over the 2012–2019 period in the eight major developed markets
- In-depth analysis of licensing and co-development agreements and an overview of key agreements that could impact growth trends
- Key drivers and restraints that have had and are expected to have a significant impact upon the market
Reasons to Buy
- Align your product portfolio to markets with high growth potential
- Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
- Devise effective, tailored strategies for each country through the understanding of key drivers and barriers in the anti-epileptic drugs market
- Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
No comments:
Post a Comment